Zobrazeno 1 - 10
of 129
pro vyhledávání: '"Aisling R Caffrey"'
Autor:
Lise E Nigrovic, Thomas H Chun, John J Halperin, Sara E Vargas, Aisling R Caffrey, Jonathan A Race, Ulrike Ott, Brynna L Morrison, Bethany J Fuller, John M VanBuren, Pedi Lyme Net
Publikováno v:
BMJ Open, Vol 13, Iss 2 (2023)
Introduction Lyme disease is the most common vectorborne disease in the Northern hemisphere with more than 400 000 new cases in the USA annually. Lyme meningitis is an uncommon but potentially serious clinical manifestation of Lyme disease. Intraveno
Externí odkaz:
https://doaj.org/article/32051ea340f3442883b365c75febabab
Autor:
Aisling R. Caffrey, Haley J. Appaneal, Vrishali V. Lopes, Laura Puzniak, Evan J. Zasowski, Luis Jodar, Kerry L. LaPlante, John M. McLaughlin
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-10 (2024)
Abstract Data evaluating effectiveness of XBB.1.5-adapted vaccines against JN.1-related endpoints are scarce. This nationwide test-negative case-control study within the US Veterans Affairs Healthcare System aims to estimate vaccine effectiveness (VE
Externí odkaz:
https://doaj.org/article/605d13443f1c4c3c87c6d49b6f0d0dac
Publikováno v:
SAGE Open Medicine, Vol 6 (2018)
Objectives: Varying statin exposures in bacteremic patients have different impacts on mortality. Among patients with adherent statin use, we sought to evaluate the impact of statin continuation on inpatient mortality in bacteremic patients. Methods:
Externí odkaz:
https://doaj.org/article/6b19d10369c54ab696d65948fb42401f
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0150795 (2016)
Prospective audit and feedback is a core antimicrobial stewardship program (ASP) strategy; however its impact is difficult to measure.Our quasi-experimental study measured the effect of an ASP on clinical outcomes, antimicrobial use, resistance, cost
Externí odkaz:
https://doaj.org/article/875d23a6855847caa9595a4d988c1ec4
Autor:
Haley J. Appaneal, Kerry L. LaPlante, Vrishali V. Lopes, Catherine Martin, Laura Puzniak, Timothy L. Wiemken, Evan J. Zasowski, John M. McLaughlin, Aisling R. Caffrey
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 1, Pp 155-172 (2024)
Abstract Introduction Limited data exist regarding real-world utilization of nirmatrelvir/ritonavir. We identified predictors of nirmatrelvir/ritonavir use among Veterans Affairs (VA) outpatients nationally. Methods We conducted a retrospective cohor
Externí odkaz:
https://doaj.org/article/a7e8dc7f27124e40a52fb31b4fce5bb7
Autor:
Aisling R. Caffrey, Haley J. Appaneal, J. Xin Liao, Emily C. Piehl, Vrishali Lopes, Laura A. Puzniak
Publikováno v:
Antibiotics, Vol 11, Iss 8, p 1033 (2022)
We have previously identified substantial antibiotic treatment heterogeneity, even among organism-specific and site-specific infections with treatment guidelines. Therefore, we sought to quantify the extent of treatment heterogeneity among patients h
Externí odkaz:
https://doaj.org/article/e88db1cf793544b6b84b3077f71574b2
Publikováno v:
COVID
Volume 3
Issue 2
Pages: 198-217
Volume 3
Issue 2
Pages: 198-217
Real-world effectiveness studies of remdesivir in hospitalized patients with COVID-19 conducted to date have produced conflicting findings which may be due, in part, to treatment heterogeneity within standard of care comparison groups. Our objective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d48b5a940fa13a6644ce1ab1aada775
Publikováno v:
Antibiotics
Volume 12
Issue 2
Pages: 224
Volume 12
Issue 2
Pages: 224
Suboptimal antibiotic prescribing may be more common in patients living in rural versus urban areas due to various factors such as decreased access to care and diagnostic testing equipment. Prior work demonstrated a rural health disparity of overpres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff76ea08fc5ec1d6e65e3ee52ac6b94f
Publikováno v:
Open Forum Infectious Diseases. 9
Background Multidrug-resistant infections are challenging to treat, due to underlying patient conditions, pathogen characteristics, and high resistance rates to antibiotic treatments. Ceftazidime/avibactam (CAZ-AVI, approved in 2015) is approved to t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aed05f24d5aa75b37fc4dfdad47b283a
https://doi.org/10.1093/ofid/ofac492.703
https://doi.org/10.1093/ofid/ofac492.703
Publikováno v:
Antimicrobial Resistance and Infection Control, Vol 6, Iss 1, Pp 1-3 (2017)
Abstract A recent study led by the Centers for Disease Control and Prevention (CDC) revealed at least 30% of antibiotic prescriptions in the outpatient setting were inappropriate. In this study of all ages, among adult patients, results were similar
Externí odkaz:
https://doaj.org/article/2e4e9ec8f213402bb4ca2175ee4b1225